Body size and weight change over adulthood and risk of breast cancer by menopausal and hormone receptor status: a pooled analysis of 20 prospective cohort studies

被引：32

作者：

van den Brandt, Piet A. ^{[1
,2
]}

Ziegler, Regina G. ^{[3
]}

Wang, Molin ^{[4
,5
,6
]}

Hou, Tao ^{[7
]}

Li, Ruifeng ^{[7
]}

Adami, Hans-Olov ^{[8
,9
]}

Agnoli, Claudia ^{[10
]}

Bernstein, Leslie ^{[11
]}

Buring, Julie E. ^{[4
,12
]}

Chen, Yu ^{[13
,14
]}

Connor, Avonne E. ^{[15
]}

Eliassen, A. Heather ^{[4
,6
]}

Genkinger, Jeanine M. ^{[16
,17
]}

Gierach, Gretchen ^{[3
]}

Giles, Graham G. ^{[18
,19
,20
,21
]}

Goodman, Gary G. ^{[22
]}

Hakansson, Niclas ^{[23
]}

Krogh, Vittorio ^{[10
]}

Le Marchand, Loic ^{[24
]}

Lee, I-Min ^{[4
,12
]}

Liao, Linda M. ^{[3
]}

Martinez, M. Elena ^{[25
,26
]}

Miller, Anthony B. ^{[27
]}

Milne, Roger L. ^{[18
,19
,20
,21
]}

Neuhouser, Marian L. ^{[22
]}

Patel, Alpa V. ^{[28
]}

Prizment, Anna ^{[29
,30
]}

Robien, Kim ^{[31
]}

Rohan, Thomas E. ^{[32
]}

Sawada, Norie ^{[33
]}

Schouten, Leo J. ^{[1
]}

Sinha, Rashmi ^{[3
]}

Stolzenberg-Solomon, Rachael Z. ^{[3
]}

Teras, Lauren R. ^{[28
]}

Tsugane, Shoichiro ^{[33
]}

Visvanathan, Kala ^{[15
]}

Weiderpass, Elisabete ^{[34
]}

White, Kami K. ^{[24
]}

Willett, Walter C. ^{[4
,6
,7
]}

Wolk, Alicja ^{[23
,35
]}

Zeleniuch-Jacquotte, Anne ^{[13
,14
]}

Smith-Warner, Stephanie A. ^{[4
,7
]}

机构：

[1] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Epidemiol, POB 616, NL-6200 MD Maastricht, Netherlands

[2] Maastricht Univ, Care & Publ Hlth Inst CAPHRI, Dept Epidemiol, POB 616, NL-6200 MD Maastricht, Netherlands

[3] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA

[4] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA

[5] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA

[6] Harvard Med Sch, Dept Med, Channing Div Network Med, Boston, MA 02115 USA

[7] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA

[8] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden

[9] Univ Oslo, Inst Hlth, Clin Effectiveness Grp, Oslo, Norway

[10] Fdn Ist Nazl Tumori, Dept Res, Epidemiol & Prevent Unit, I-20133 Milan, Italy

[11] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA USA

[12] Harvard Med Sch, Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA

[13] NYU, Sch Med, Div Epidemiol, Dept Populat Hlth, New York, NY USA

[14] NYU, Sch Med, Dept Environm Med, New York, NY USA

[15] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA

[16] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA

[17] Columbia Univ, Irving Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY USA

[18] Canc Council Victoria, Canc Epidemiol Div, Melbourne, Vic, Australia

[19] Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia

[20] Monash Univ, Precis Med, Sch Clin Sci, Clayton, Vic, Australia

[21] Monash Univ, Monash Hlth, Clayton, Vic, Australia

[22] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA

[23] Karolinska Inst, Inst Environm Med, Unit Cardiovasc & Nutr Epidemiol, Stockholm, Sweden

[24] Univ Hawaii, Ctr Canc, Canc Epidemiol Program, Honolulu, HI 96822 USA

[25] Univ Calif San Diego, Sch Med, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA

[26] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA

[27] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada

[28] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA

[29] Univ Minnesota, Sch Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA

[30] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA

[31] George Washington Univ, Sch Publ Hlth, Milken Inst, Dept Exercise & Nutr Sci, Washington, DC USA

[32] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA

[33] Natl Canc Ctr, Epidemiol & Prevent Grp, Res Ctr Canc Prevent & Screening, Tokyo, Japan

[34] WHO, Int Agcy Res Canc, Lyon, France

[35] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden

来源：

EUROPEAN JOURNAL OF EPIDEMIOLOGY | 2021年 / 36卷 / 01期

基金：

美国国家卫生研究院;

关键词：

Breast neoplasms; Body height; Body weight; Weight change; Estrogen receptor; Cohort studies; MASS INDEX; POSTMENOPAUSAL WOMEN; REGRESSION-MODELS; PHYSICAL-ACTIVITY; SEX-HORMONES; EARLY-LIFE; ESTROGEN; PROGESTERONE; GROWTH; METAANALYSIS;

D O I：

10.1007/s10654-020-00688-3

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Associations between anthropometric factors and breast cancer (BC) risk have varied inconsistently by estrogen and/or progesterone receptor (ER/PR) status. Associations between prediagnostic anthropometric factors and risk of premenopausal and postmenopausal BC overall and ER/PR status subtypes were investigated in a pooled analysis of 20 prospective cohorts, including 36,297 BC cases among 1,061,915 women, using multivariable Cox regression analyses, controlling for reproductive factors, diet and other risk factors. We estimated dose-response relationships and tested for nonlinear associations using restricted cubic splines. Height showed positive, linear associations for premenopausal and postmenopausal BC risk (6-7% RR increase per 5 cm increment), with stronger associations for receptor-positive subtypes. Body mass index (BMI) at cohort baseline was strongly inversely associated with premenopausal BC risk, and strongly positively-and nonlinearly-associated with postmenopausal BC (especially among women who never used hormone replacement therapy). This was primarily observed for receptor-positive subtypes. Early adult BMI (at 18-20 years) showed inverse, linear associations for premenopausal and postmenopausal BC risk (21% and 11% RR decrease per 5 kg/m(2), respectively) with stronger associations for receptor-negative subtypes. Adult weight gain since 18-20 years was positively associated with postmenopausal BC risk, stronger for receptor-positive subtypes, and among women who were leaner in early adulthood. Women heavier in early adulthood generally had reduced premenopausal BC risk, independent of later weight gain. Positive associations between height, baseline (adult) BMI, adult weight gain and postmenopausal BC risk were substantially stronger for hormone receptor-positive versus negative subtypes. Premenopausal BC risk was positively associated with height, but inversely with baseline BMI and weight gain (mostly in receptor-positive subtypes). Inverse associations with early adult BMI seemed stronger in receptor-negative subtypes of premenopausal and postmenopausal BC.

引用

页码：37 / 55

页数：19

共 50 条

[41] Physical activity, hormone replacement therapy and breast cancer risk: A meta-analysis of prospective cohort studies
Autier, P.
Pizot, C.
Boniol, M.
Mullie, P.
Koechlin, A.
Boniol-Rech, M.
Bolli, G.
Rosenstock, J.
Boyle, P.
[J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : S70 - S71
[42] Body size and risk for breast cancer in relation to estrogen and progesterone receptor status in Japan
Iwasaki, Motoki
Otani, Tetsuya
Inoue, Manami
Sasazuki, Shizuka
Tsugane, Shoichiro
[J]. ANNALS OF EPIDEMIOLOGY, 2007, 17 (04) : 304 - 312
[43] Adult Body Size, Hormone Receptor Status, and Premenopausal Breast Cancer Risk in a Multiethnic Population The San Francisco Bay Area Breast Cancer Study
John, Esther M.
Sangaramoorthy, Meera
Phipps, Amanda I.
Koo, Jocelyn
Horn-Ross, Pamela L.
[J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 (02) : 201 - 216
[44] Birthweight, childhood body size, and timing of puberty and risks of breast cancer by menopausal status and tumor receptor subtypes
Pedersen, Dorthe C.
Jensen, Britt W.
Tjonneland, Anne
Andersen, Zorana J.
Mellemkjaer, Lene
Bjerregaard, Lise G.
Aarestrup, Julie
Baker, Jennifer L.
[J]. BREAST CANCER RESEARCH, 2022, 24 (01)
[45] Birthweight, childhood body size, and timing of puberty and risks of breast cancer by menopausal status and tumor receptor subtypes
Dorthe C. Pedersen
Britt W. Jensen
Anne Tjønneland
Zorana J. Andersen
Lene Mellemkjaer
Lise G. Bjerregaard
Julie Aarestrup
Jennifer L. Baker
[J]. Breast Cancer Research, 24
[46] Sex Hormone Levels, Breast Cancer Risk, and Cancer Receptor Status in Postmenopausal Women: the ORDET Cohort
Sieri, Sabina
Krogh, Vittorio
Bolelli, Gianfranco
Abagnato, Carlo Alberto
Grioni, Sara
Pala, Valeria
Evangelista, Alberto
Allemani, Claudia
Micheli, Andrea
Tagliabue, Giovanna
Schunemann, Holger J.
Menard, Sylvie
Berrino, Franco
Muti, Paola
[J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (01) : 169 - 176
[47] Energy homeostasis genes and breast cancer risk: The influence of ancestry, body size, and menopausal status, the breast cancer health disparities study
Slattery, Martha L.
Lundgreen, Abbie
Hines, Lisa
Wolff, Roger K.
Torres-Mejia, Gabriella
Baumgartner, Kathy N.
John, Esther M.
[J]. CANCER EPIDEMIOLOGY, 2015, 39 (06) : 1113 - 1122
[48] Grain and dietary fiber intake and bladder cancer risk: a pooled analysis of prospective cohort studies
Yu, Evan Y. W.
Wesselius, Anke
Mehrkanoon, Siamak
Brinkman, Maree
van den Brandt, Piet
White, Emily
Weiderpass, Elisabete
Le Calvez-Kelm, Florence
Gunter, Marc
Huybrechts, Inge
Liedberg, Fredrik
Skeie, Guri
Tjonneland, Anne
Riboli, Elio
Giles, Graham G.
Milne, Roger L.
Zeegers, Maurice P.
[J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2020, 112 (05): : 1252 - 1266
[49] Lifetime alcohol intake and stomach cancer risk: a pooled analysis of two prospective cohort studies
Jayasekara, Harindra
MacInnis, Robert
Yang, Yi
Hodge, Allison
Mitchell, Hazel
Haydon, Andrew
Room, Robin
Hopper, John
Gunter, Marc
Riboli, Elio
Giles, Graham
Milne, Roger
English, Dallas
Ferrari, Pietro
[J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2021, 50 : 114 - 114
[50] Colorectal cancer risk following appendectomy: a pooled analysis of three large prospective cohort studies
Rothwell, Joseph A.
Mori, Nagisa
Artaud, Fanny
Fournier, Agnes
Conte, Marco
Boutron-Ruault, Marie-Christine
Chan, Simon S. M.
Gunter, Marc J.
Murphy, Neil
Severi, Gianluca
[J]. CANCER COMMUNICATIONS, 2022, 42 (05) : 486 - 489

← 1 2 3 4 5 →